Loading...
•
Sep 30, 2020
Teladoc Q3 2020 Earnings Report
Teladoc Health experienced strong revenue growth and increased total visits, driven by broad-based strength across the business.
Key Takeaways
Teladoc Health reported a 109% year-over-year increase in Q3 revenue, reaching $288.8 million. Total visits also saw a significant increase of 206% to 2.8 million. The company issued Q4 guidance and raised full-year expectations, highlighting new client partnerships and sustainable growth.
Q3 revenue grew 109% year-over-year to $288.8 million.
Total visits increased 206% year-over-year to 2.8 million.
New and expanded client partnerships were established with industry leaders.
The company highlighted continued growth in specialty visits and registrations.
Revenue by Geographic Location
Forward Guidance
For the fourth quarter of 2020, Teladoc Health expects total revenue to be in the range of $294 million to $304 million and total visits to be between 2.8 million and 3.0 million. For the full year 2020, the company expects total revenue to be in the range of $1,005 million to $1,015 million and total visits to be between 10.4 million to 10.6 million.
Positive Outlook
- Total revenue to be in the range of $294 million to $304 million for Q4 2020.
- Adjusted EBITDA to be in the range of $21 million to $24 million for Q4 2020.
- Total U.S. paid membership to be in the range of 50 million to 51 million members for Q4 2020.
- Visit-fee-only access to be available to 21 to 22 million individuals for Q4 2020.
- Total visits to be between 2.8 million and 3.0 million for Q4 2020.
Challenges Ahead
- EBITDA (loss), excluding transaction costs related to the pending Livongo merger, to be in the range of $(1) million to $2 million for Q4 2020.
- Net loss per share, excluding all transaction costs related to the pending Livongo merger, to be between $(0.36) and $(0.33) for Q4 2020.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...